XIFR Q1 2026 Earnings Significant EPS Beat Driven by Operational Strength Xeris Biopharma XERS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates SGMT Q1 2026 Earnings EPS Beat as Clinical Development Costs Tighten ZENA Q4 2025 Earnings Significant EPS Miss Amid Surprising Stock Rally CUE Q3 2025 Earnings Narrower Loss Drives Positive Market Response Oxford Lane Capital Corp 875 Notes 2030 OXLCI Modest Gain Amid Stable Yield Positioning Bogota Financial Corp BSBK Slips 118 as Stock Tests Key Support Near 800 Kemper Corporation KMPR Holds Steady Near Support as Consolidation Continues Sotherly Hotels Preferred Stock SOHON Holds Steady Near Support Zone KT Q1 2026 Earnings EPS Miss Drives Slight Stock Decline